Harvard Medical School Diabetes Update 2023

Categories: - MUS, Endocrinology & Nutrition, Harvard Medicine, Internal Medicine, Obesity Medicine, Uncategorized Tags: alpha-glucosidase inhibitors, anti-diabetes medications, biguanides, carbohydrate-insulin model, cardiologists, cardiovascular risk diabetes, clinical pharmacists, congestive heart failure diabetes, Continuous glucose monitoring, diabesity, diabetes and cultural factors, diabetes and depression, diabetes and exercise, diabetes and heart failure, diabetes and hypertension, diabetes and lipid management, diabetes and liver disease, diabetes and nutrition, diabetes and obesity, diabetes and socioeconomic factors, diabetes barriers, diabetes best practices, diabetes cardiovascular complications, diabetes care, diabetes care education, diabetes care optimization, diabetes case discussions, diabetes clinical strategies, Diabetes CME, Diabetes complications, diabetes conference, diabetes course, diabetes course Harvard medical professionals, diabetes diagnosis, diabetes education resources, diabetes educators, diabetes evidence-based care, diabetes for clinicians, diabetes for dietitians, diabetes for endocrinologists, diabetes for healthcare professionals, diabetes for internists, diabetes for medical educators, Diabetes for nurse practitioners, diabetes for pharmacists, Diabetes for physician assistants, diabetes for primary care, diabetes for specialists, diabetes guideline updates, diabetes health disparities, diabetes health literacy, diabetes in elderly, diabetes in elderly patients, diabetes in high-risk patients, diabetes in low socioeconomic patients, diabetes in minorities, diabetes management, Diabetes Management Course, diabetes nutrition guidelines, diabetes online CME, Diabetes online course, diabetes patient education, diabetes patient engagement, diabetes phenotypes, diabetes practice guidelines, diabetes practice impact, diabetes Q&A, diabetes remote education, diabetes remote learning, diabetes renal complications, diabetes research breakthroughs, diabetes surgical management, diabetes technology, diabetes technology advances, diabetes therapeutic interventions, diabetes therapies, diabetes treatment plans, diabetes treatment updates, diabetes update, Diabetes Update 2023, Diabetes Update course, Diabetes Update Harvard Harvard Medical School, Diabetes Update live streaming, Diabetes Update online, Diabetes Update program, dietitians, DPP-4 inhibitors, DPP-IV inhibitors, dyslipidemia diabetes, dyslipidemia in diabetes, elderly diabetes care, endocrinologists, evidence-based diabetes care, exercise prescription diabetes, GLP-1 receptor agonists, Harvard CME, Harvard CME diabetes, Harvard diabetes conference, Harvard diabetes course, Harvard Diabetes Course Online, Harvard diabetes education, Harvard Diabetes Live Streaming, Harvard Diabetes program, Harvard diabetes training, Harvard diabetes update, Harvard Diabetes Update 2023, harvard medical cme, Harvard Medical School Diabetes Update, HDL triglycerides diabetes, healthcare providers Harvard Medical School Diabetes Update, HMS diabetes update, hypertension in diabetes, hypertension management diabetes, incretin-based therapies, insulin pumps, insulin therapy, LDL cholesterol diabetes, LDL management, medical nutrition therapy, metabolic liver disease, NAFLD diabetes, NAFLD in diabetes, nephrologists, non-alcoholic fatty liver disease, nurse practitioners, obesity management, physical activity diabetes, physical activity in diabetes, physician assistants, practice guidelines diabetes, primary care physicians, renal complications diabetes, renal disease diabetes, SGLT-2 inhibitors, SGLT2 inhibitors, sulfonylureas, thiazolidinediones, type 1 diabetes, type 2 diabetes Brand: CMEMEDCOM

Description

Diabetes Update 2023

Live Streaming • May 3 – 6, 2023

The Harvard Medical School Diabetes Update

Diabetes Update will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.

EDUCATION to MEET THE CHALLENGES of DIABETES CARE

At a time when our diabetes knowledge and treatment options have advanced so much, why do clinical outcomes remain suboptimal, with so many patients unable to achieve good control of their disease?

The answer is rooted in four challenges:

Keeping pace with rapidly advancing clinical options for diabetes care:
- Therapies
- Technologies
- Lifestyle medicine interventions
Designing comprehensive therapeutic interventions based on frequent diabetes-associated diseases and complications
Accounting for a patient’s unique biological, psychological, social, financial, educational, and cultural factors
Overcoming structural healthcare barriers that require clinical strategies to fit within a particular mold

This course is designed to equip clinicians to meet these challenges, providing practical, evidence-based approaches to optimize care for your patients.

STRATEGIES, UPDATES, and BEST PRACTICES for STATE-OF-THE-ART DIABETES CARE

This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.

Participants can rely on this program for comprehensive education to ensure state-of-the-art treatment. Coverage includes:

Design of more effective treatment plans
Current anti-diabetes medications and how to use them
Diagnosis of different types of diabetes
Utilization of recent technology advances in diabetes care
Optimizing care for people with obesity
Assessing and treating cardiovascular and renal complications
Guiding patients on physical activity and medical nutrition
Management of hypertension and dyslipidemia
Addressing low engagement in therapy

NEW DATA and PRACTICE GUIDELINES for DIABETES CARE

The newest data on the identification of different types of diabetes
The latest scientific information on how to reduce cardiovascular and renal disease risk in patients with type 2 diabetes
New guidelines and practice recommendations for nutrition and physical activity coupled with instruction to incorporate them into your current approaches to diabetes care
Criteria to navigate the controversial data related to some anti-diabetes medications
Medical vs. surgical management of obesity
New technologies in diabetes care: updates and implications for day-to-day care
Research breakthroughs
Tips and tricks for navigating barriers within healthcare systems

ASSESSMENT and TREATMENT of COMPLICATIONS from DIABETES

The 2023 program provides education to assess and treat:

Cardiovascular Disease
Congestive Heart Failure
Renal Disease
Non-Alcoholic Liver Disease

OPTIMIZING HEALTH OUTCOMES for DIFFERENT PATIENTS

This program also provides comprehensive guidance to account for biological, psychological, emotional, social, financial, and cultural factors that impact the development and progression of diabetes.

Coverage includes:

Racial and ethnic minorities
The elderly
People with obesity
Patients at high cardiovascular risk
Individuals with low engagement in therapy
Patients at low socio-economic levels
Subjects with low health literacy/education
Individuals with depression/emotional distress
Patients with metabolic liver disease

PRACTICE IMPACT

Over four days, you will gain new, encompassing, evidence-based approaches to address the challenges seen in most clinical practices. More importantly, you will leave with knowledge—part art, part science—to make a real difference in the lives of your patients.

OPTIMIZED for REMOTE EDUCATION

The 2023 program has been enhanced for distance learning. In addition to being live streamed, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.

Along with recordings and course presentations, additional resources such as guidelines, recent articles and relevant patient education materials will also be available.

Schedule

All times listed below are Eastern Daylight Time.

Wednesday, May 03, 2023

9:30am to 9:45am

Welcome and IntroductionA. Enrique Caballero, MD

Opening Lecture

9:45am to 10:15am

Diabetes Report Card: How Are We Doing in Diabetes Care?A. Enrique Caballero, MD

Identifying Various Types of Diabetes in Clinical Practice

10:15am to 10:35am	Practical Approach to Identifying Different Types of Diabetes in Clinical PracticeLucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
10:35am to 10:55am	Current Understanding of Diabetes PhenotypesMiriam Udler, MD, PhD
10:55am to 11:10am	Break
11:10am to 11:50am	Q & A and Clinical Cases DiscussionLucia Novak, MSN, ANP-BC, BC-ADM, CDTC and Miriam Udler, MD, PhD

Management of Diabetes in the Elderly

11:50am to 12:10pm	Type 2 Diabetes in the Elderly: What You Need to KnowMedha Munshi, MD
12:10pm to 12:30pm	A Practical Approach to Anti-Diabetes Medication SelectionMarie McDonnell, MD
12:30pm to 1:10pm	Q & A and Clinical Cases DiscussionMedha Munshi, MD and Marie McDonnell, MD
1:10pm to 1:55pm	Break

Medical Nutrition Management in Diabetes and Obesity

1:55pm to 2:15pm	Current Nutrition Recommendations and GuidelinesLaura Andromalos, MS, RD, RN, CSOWM, CDCES
2:15pm to 2:35pm	The Carbohydrate-Insulin Model: A Novel Approach to DiabesityDavid Ludwig, MD, PhD
2:35pm to 3:15pm	Q & A and Clinical Case DiscussionLaura Andromalos, MS, RD, CSOWM, CDCES and David Ludwig, MD, PhD
3:15pm to 3:45pm	Interactive Breakout Sessions

Thursday, May 04, 2023

9:30am to 9:40am

Welcome, Recap of Day 1, and Description of Day 2 ActivitiesA. Enrique Caballero, MD

Special Lecture

9:40am to 10:15am

Non-Alcoholic Fatty Liver DiseaseScott Isaacs, MD, FACP, FACE

Prescribing Exercise to Patients with Diabetes

10:15am to 10:35am	Exercise in Diabetes Care: The Basics on What Works and WhyJane Reusch, MD
10:35am to 10:55am	Exercise Recommendations: Building a Tailored Program considering Diabetes Status and ComplicationsJacqueline Shahar, MEd, RCEP, CDCES
10:55am to 11:10am	Break
11:10am to 11:50am	Q & A and Clinical Case DiscussionJane Reusch, MD and Jacqueline Shahar, MEd, RCEP, CDCES

Obesity Management: The Controversies

11:50am to 12:10pm	Pharmacological Management: Individualizing TherapyW. Scott Butsch, MD, MSc
12:10pm to 12:30pm	Surgical Management: Why and When?Philip R. Schauer, MD
12:30pm to 1:10pm	Q & A and Clinical Cases DiscussionW. Scott Butsch, MD, MSc and Philip R. Schauer, MD
1:10pm to 1:55pm	Break

Dyslipidemia Management in the Patient with DM

1:55pm to 2:15pm	Addressing LDL: Cholesterol as Primary TargetOm Ganda, MD
2:15pm to 2:35pm	Triglycerides and HDL: Cholesterol Management—When and How?Aruna Pradhan, MD, MPH
2:35pm to 3:15pm	Q & A and Clinical Case DiscussionOm Ganda,MD and Aruna Pradhan, MD, MPH
3:15pm to 3:45pm	Interactive Breakout Sessions

Friday, May 05, 2023

9:30am to 9:40am

Welcome, Recap of Day 2 and Description of Day 3 ActivitiesA. Enrique Caballero, MD

Special Lecture

9:40am to 10:15am

The Microbiome in Obesity, Diabetes, and Related DisordersPatricia Davidson, DCN, RDN, LDN, CDCES, FAND, CHSE, FADCES

Hypertension Management in the Patient with Diabetes

10:15am to 10:35am	Clinical Evaluation of the Patient with HypertensionNaomi Fisher, MD
10:35am to 10:55am	Current Recommendations for the Treatment of HypertensionJohn Forman, MD
10:55am to 11:10am	Break
11:10am to 11:50am	Q & A and Clinical Case DiscussionNaomi Fisher, MD and John Forman, MD

Cardiovascular Risk Reduction

11:50am to 12:10pm	Evaluation of CV Risk: Practical RecommendationsJorge Plutzky, MD
12:10pm to 12:30pm	Reducing CV Risk in the Patient with Diabetes: A Comprehensive ApproachChristopher Cannon, MD
12:30pm to 1:10pm	Q & A and Clinical Case DiscussionJorge Plutzky, MD and Christopher Cannon, MD
1:10pm to 1:55pm	Break

Technology Advances in the Management of Diabetes

1:55pm to 2:15pm	Continuous Glucose Monitoring: A 2023 VisionDevin Steenkamp, MD
2:15pm to 2:35pm	Insulin Pumps, Closing the Loop: Where Do We Stand?Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
2:35pm to 3:15pm	Q & A and Clinical Cases DiscussionDevin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
3:15pm to 3:45pm	Interactive Breakout Sessions

Saturday, May 06, 2023

9:30am to 9:40am

Welcome, Recap of Day 3 and Description of Day 4 ActivitiesA. Enrique Caballero, MD

Pharmacological Management of Diabetes

9:40am to 10:00am	Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)A. Enrique Caballero, MD
10:00am to 10:20am	Incretin-Based Therapies (DPP-IV Inhibitors and GLP-1 RA)Juan P. Frias, MD
10:20am to 10:40am	SGLT-2 InhibitorsSilvio Inzucchi, MD
10:40am to 11:00am	Insulin TherapyAnne L. Peters, MD
11:00am to 11:10am	Break
11:10am to 12:10pm	Q & A and Clinical Cases DiscussionA. Enrique Caballero, MD, Juan P. Frias, MD, Silvio Inzucchi, MD, and Anne L. Peters, MD
12:10pm to 1:10pm	Break

Addressing Diversity in Diabetes Care

1:10pm to 1:40pm	How Do Race and Ethnicity Influence Diabetes Management Decisions?A. Enrique Caballero, MD
1:40pm to 2:10pm	Identifying Community-Based Resources to Help Patients with DiabetesJosh Trautwein
2:10pm to 2:30pm	Q & A Clinical Cases DiscussionA. Enrique Caballero, MD

Keynote Lecture

2:30pm to 3:15pm	The Road towards Equity in Diabetes CareJanet Brown-Friday, RN, MSN, MPH
3:15pm to 3:45pm	Interactive Breakout Sessions
3:45pm to 3:50pm	Closing RemarksA. Enrique Caballero, MD

Harvard Medical School Diabetes Update 2023

The Harvard Medical School Diabetes Update

Opening Lecture

Identifying Various Types of Diabetes in Clinical Practice

Management of Diabetes in the Elderly

Medical Nutrition Management in Diabetes and Obesity

Special Lecture

Prescribing Exercise to Patients with Diabetes

Obesity Management: The Controversies

Dyslipidemia Management in the Patient with DM

Special Lecture

Hypertension Management in the Patient with Diabetes

Cardiovascular Risk Reduction

Technology Advances in the Management of Diabetes

Pharmacological Management of Diabetes

Addressing Diversity in Diabetes Care

Keynote Lecture

Related products

Login